Annual mammograms are important and AdventHealth now offers enhanced screening for women with dense breast tissue as well as ...

Raleigh, N.C., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Wake Radiology just completed its “We See the Difference” breast cancer ...

Asset Management One Co. Ltd. cut its holdings in Hologic, Inc. (NASDAQ:HOLX – Free Report) by 0.5% in the 3rd quarter, ...

Global Breast Cancer Screening Tests Market was valued at approximately USD 2.93 billion in 2023 and is projected to grow with a healthy CAGR of 54.3% over the forecast period 2024-2032. Read the ...

Hologic (HOLX – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Tejas Savant ...

Analyst Michael Matson from Needham reiterated a Buy rating on Hologic (HOLX – Research Report) and keeping the price target at $90.00.

Q4 2024 Earnings Call Transcript November 4, 2024 Hologic, Inc. reports earnings inline with expectations. Reported EPS is $1 ...

The firm reported a 13 percent jump in its non-COVID molecular diagnostics revenues year over year while its breast health and GYN Surgical business revenues rose 6 percent.

Good afternoon, and welcome to the Hologic's Fourth Quarter Fiscal 2024 Earnings Conference Call. My name is Shelly, and I am your operator for today’s call. Today's conference is being recorded. All ...

Company Expects Strong Execution of its Broad-Based Growth Strategy in Fiscal 2025 – MARLBOROUGH, Mass., November 04, ...